Search This Blog

Thursday, August 1, 2019

Iovance Biotherapeutics EPS misses by $0.09

Iovance Biotherapeutics (NASDAQ:IOVA): Q2 GAAP EPS of -$0.38 misses by $0.09.
Cash, equivalents, and short-term investments of $404.15M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)